West Tower Group’s ICU Medical ICUI Stock Holding History

West Tower Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-60	Closed	-$10.7K	–	700
2023 Q2	$10.7K	Buy	+60	New	+$11K	0.01%	422

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

West Tower Group's ICUI Position: Q3 2023 in Review

West Tower Group sold out of ICU Medical (ICUI) in Q3 2023, closing a stake of 60 shares — an estimated $10.7K sold.

West Tower Group first reported a position in ICUI in Q2 2023 and held it in 1 quarter. The position peaked at $10.7K in Q2 2023. 220 funds tracked by Wall St. Rank hold ICUI as of Q3 2023.

West Tower Group reported no remaining ICU Medical position as of Q3 2023 after selling out during the quarter.
West Tower Group sold 60 ICU Medical shares in Q3 2023, an estimated $10.7K.
West Tower Group first reported a position in ICU Medical in Q2 2023 and held it in 1 quarter.
West Tower Group's ICU Medical position peaked at $10.7K in Q2 2023.
220 funds tracked by Wall St. Rank held ICU Medical as of Q3 2023.

Based on West Tower Group's 13F filing for Q3 2023, filed 14 Nov 2023.